Skip to main content
. Author manuscript; available in PMC: 2008 Oct 28.
Published in final edited form as: Hypertens Res. 2004 Jul;27(7):493–500. doi: 10.1291/hypres.27.493

Fig. 1.

Fig. 1

Temporal profiles of systolic blood pressure (SBP). SBP was similar among the 4 groups at the beginning of the protocol. Endothelin (ET)-1 infusion for 2 weeks significantly increased SBP. Concurrent administration of olmesartan or hydralazine prevented the development of hypertension in ET-1-infused rats. *p<0.05 vs. week 0.